This prestigious Prix Galien Award each year, recognises outstanding achievements in 5 categories Medicines, Research Work, Medical Devices, E-Health and Accompanying Patient, that improves the global human condition. Originally founded in France in 1970, is now awarded in ten countries around the world with France as our Prix Galien Award country.
“This nomination not only highlights the breakthrough technology behind Hypernova Chronos in High Level Disinfection, but the unrivalled team that worked to develop and bring it to market. An innovation with the potential to make a significant impact in reducing cross-infection over repeated use of ultrasound transducers as a vector for pathogen transmission,” said Clement Deshays, CEO of Germitec. “The innovation improves ultrasound examination environment at the patient’s bedside, and in particular in the context of ultrasound-guided procedures and pulmonary ultrasound examinations in Emergency, Intensive Care or Resuscitation.”